Funding to Develop Bioreactors for Reparative Medicine: Webinar

Date/Time
Date(s) - 12 Sep 2014 until 12 Sep 2014
12:00 PM - 1:00 PM

Location
Webinar


NHLBI

Over $21M in New Funding Available for

Bioreactors for Reparative Medicine

Learn about it at the

Funding to Develop Bioreactors

for Reparative Medicine Webinar

on September 12, 2014

Noon in AZ (3PM EST)

 

Register-Now-Button

 

The National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Center for Advancing Translational Sciences (NCATS) announce a new program that aims to support multidisciplinary small business teams in the development of complex, three-dimensional engineering systems for growing heart, lung, or bone marrow tissue.

Ultimately, bioreactor designs should provide the most physiologically relevant environment to promote correct 3-dimensional tissue growth and maintenance, which is also efficient, safe and economical.  Such devices should be made commercially available and widely disseminated to researchers for application in the translational setting.

 

This new Bioreactors for Reparative Medicine opportunity is offered through the:

 

Small Business Innovation Research (SBIR) mechanism (R43/R44)

  • Phase I, Phase II, and Fast Track options—RFA-HL-15-008—next due date 10/10/14
  • Direct to Phase II—RFA-HL-15-017—next due date 10/14/15

 

Small Business Technology Transfer (STTR) mechanism (R41/R42)

  • Phase I, Phase II, and Fast Track options—RFA-HL-15-004—next due date 10/10/14

 

For questions about these funding opportunities, contact:

Martha S. Lundberg, PhD
Program Director, Division of Cardiovascular Sciences

Email: lundberm@nhlbi.nih.gov

 

For general questions about the NHLBI SBIR/STTR programs, contact:

Jennifer C. Shieh, PhD

Small Business Coordinator, Office of Translational Alliances & Coordination

Email: jennifer.shieh@nih.gov

 

The NHLBI SBIR/STTR Programs provide support for small businesses developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding for research and development of technologies related to the mission of NHLBI.

 

For more information about the NHLBI SBIR/STTR Program, including funding opportunities,

visit the NHLBI  web page.@NHLBI_SBIR

 

Sign up to receive updates or adjust your subscription at the NHLBI-SBIR subscriber page.